MedTrace Logo

Optimize the Requirements and Preparations in Outpatient Chemotherapy

NCT02323555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 624

Last updated 2017-02-10

No results posted yet for this study

Summary

A prescription of injectable anticancer therapy requires the collection of medical data (interview and physical examination) and often allied (laboratory tests). This requirement is made on the day of the arrival of the patient to not prepare these treatments incorrectly.

After receiving the prescription of treatment, it will take about 1 hour to prepare for pharmacy and more in times of high activity, to provide the day hospital pockets treatment, incompressible time when the patient waits to have his treatment.

A process has been selected (Optima) to anticipate prescribing injectable cancer treatments and their manufacturing to reduce patient waiting times on the day of his coming François BaclesseCentre day hospital.

Conditions

  • Cancer
  • IV Anticancer Therapy

Interventions

OTHER

Paramedic telephone consultation

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Centre Francois Baclesse

    lead OTHER

Principal Investigators

  • Audrey FAVEYRIAL, MD · Centre François Baclesse

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-07-31
Completion
2016-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02323555 on ClinicalTrials.gov